Effectiveness of Nifurtimox in the Treatment of Chagas Disease: a Long-Term Retrospective Cohort Study in Children and Adults

Chagas disease (ChD), caused by Trypanosoma cruzi, has a global prevalence due to patient migration. However, despite its worldwide distribution, long-term follow-up efficacy studies with nifurtimox (NF) are scarce and have been conducted with only small numbers of patients. A retrospective study of...

Descripción completa

Detalles Bibliográficos
Autores principales: Falk, N., Berenstein, A. J., Moscatelli, G., Moroni, S., González, N., Ballering, G., Freilij, H., Altcheh, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Clinical Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112880/
https://www.ncbi.nlm.nih.gov/pubmed/35416710
http://dx.doi.org/10.1128/aac.02021-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112880/
https://www.ncbi.nlm.nih.gov/pubmed/35416710
http://dx.doi.org/10.1128/aac.02021-21

Ejemplares similares